The burden of gastroenteritis in Switzerland (BUGS) study: a research proposal for a 1-year, prospective cohort study
- PMID: 30445997
- PMCID: PMC6240284
- DOI: 10.1186/s13104-018-3916-2
The burden of gastroenteritis in Switzerland (BUGS) study: a research proposal for a 1-year, prospective cohort study
Abstract
Objectives: Acute gastroenteritis (AG) is a usually self-limiting, but common disease worldwide. In Europe, incidence estimates range from 0.3-1.5 AG episodes/person-year. For Switzerland, available information on AG is restricted to notifiable foodborne diseases and findings from research studies starting at primary care level. The aims of this 1-year, population-based prospective cohort study are to assess the incidence, burden of disease, aetiology and socio-economic impact of AG in the Swiss general population. Additionally, the prevalence of bacterial gastrointestinal pathogens and bacteria harbouring antimicrobial resistances in the asymptomatic population shall be assessed.
Results: Weekly follow-up of the cohort consisting of 3000 participants will provide incidence estimates of AG. Furthermore, information collected will be used to assess risk factors for experiencing an episode of AG, to explore determinants for help seeking, and to characterise the socio-economic impact of AG including absence from work and inability to perform daily activities. Aetiology of AG is determined by investigating stool samples from symptomatic participants. Finally, stool samples from participants collected during an asymptomatic period will be used to assess the prevalence of enterohaemorrhagic E. coli, Campylobacter spp., Salmonella spp. and Shigella spp. as well as of resistance to different antibiotics (extended-spectrum beta-lactamase-, fluoroquinolone- and carbapenemase-resistance).
Keywords: Acute gastroenteritis; Aetiology; Antibiotic resistance; Burden of disease; Cohort study; Incidence; Research proposal; Switzerland.
Figures



Similar articles
-
Acute gastroenteritis in primary care: a longitudinal study in the Swiss Sentinel Surveillance Network, Sentinella.Infection. 2017 Dec;45(6):811-824. doi: 10.1007/s15010-017-1049-5. Epub 2017 Aug 4. Infection. 2017. PMID: 28779435 Free PMC article.
-
Acute Gastroenteritis and Campylobacteriosis in Swiss Primary Care: The Viewpoint of General Practitioners.PLoS One. 2016 Sep 7;11(9):e0161650. doi: 10.1371/journal.pone.0161650. eCollection 2016. PLoS One. 2016. PMID: 27603141 Free PMC article.
-
Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003).Int J Antimicrob Agents. 2006 May;27(5):367-75. doi: 10.1016/j.ijantimicag.2005.12.004. Int J Antimicrob Agents. 2006. PMID: 16647842
-
Estimating the burden of foodborne diseases in Japan.Bull World Health Organ. 2015 Aug 1;93(8):540-549C. doi: 10.2471/BLT.14.148056. Epub 2015 Jun 1. Bull World Health Organ. 2015. PMID: 26478611 Free PMC article. Review.
-
Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.Hum Vaccin Immunother. 2015;11(3):601-19. doi: 10.1080/21645515.2015.1011578. Hum Vaccin Immunother. 2015. PMID: 25715096 Free PMC article. Review.
References
-
- Scallan E, Fitzgerald M, Collins C, Crowley D, Daly L, et al. Acute gastroenteritis in northern Ireland and the Republic of Ireland: a telephone survey. Commun Dis Public Health. 2004;7:61–67. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous